See more : Trillium Therapeutics Inc. (TRIL) Income Statement Analysis – Financial Results
Complete financial analysis of High Fusion Inc. (SPLIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of High Fusion Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Taurus Armas S.A. (TASA3.SA) Income Statement Analysis – Financial Results
- Elme Communities (WRE) Income Statement Analysis – Financial Results
- Geekay Wires Limited (GEEKAYWIRE.NS) Income Statement Analysis – Financial Results
- Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust (PROSPECT.BK) Income Statement Analysis – Financial Results
- Upsurge Investment & Finance Ltd. (UPSURGE.BO) Income Statement Analysis – Financial Results
High Fusion Inc. (SPLIF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.high-fusion.com
About High Fusion Inc.
High Fusion Inc. focuses on developing and manufacturing branded products in the cannabis industry with a specific focus on flower, pro-rolls, vapes, edibles, and oil extracts for medical and adult recreational use in the United States. Its brand portfolio includes FLÏ edibles and vape product, OutCo, and Thrive brands. The company was formerly known as Nutritional High International Inc. and changed its name to High Fusion Inc. in November 2021. High Fusion Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 6.25M | 96.07K | 12.34M | 23.61M | 5.81M | 854.57K | 608.28K | 202.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 5.00M | 75.72K | 9.55M | 18.13M | 5.05M | 284.95K | 72.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 1.25M | 20.34K | 2.79M | 5.48M | 763.14K | 569.62K | 535.32K | 202.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 19.95% | 21.18% | 22.59% | 23.22% | 13.12% | 66.66% | 88.01% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 7.88M | 4.43M | 9.94M | 17.44M | 6.20M | 3.54M | 1.90M | 1.80M | 325.33K | 73.68K | 146.70K | 46.68K | 55.20K | 0.00 |
Selling & Marketing | 0.00 | 245.28K | 78.05K | 1.66M | 1.68M | 560.71K | 117.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 8.12M | 4.51M | 11.60M | 19.12M | 6.20M | 3.54M | 1.90M | 1.80M | 325.33K | 73.68K | 146.70K | 46.68K | 55.20K | 3.45K |
Other Expenses | 0.00 | 65.28K | -245.69K | -1.04M | 224.31K | 211.81K | 660.22K | 515.32K | 202.27K | -355.82K | 0.00 | 4.99K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 10.14M | 5.12M | 14.33M | 22.36M | 8.10M | 5.46M | 2.33M | 1.93M | 325.33K | 73.68K | 146.70K | 46.68K | 55.20K | 3.45K |
Cost & Expenses | 0.00 | 15.14M | 5.20M | 23.88M | 40.49M | 13.15M | 5.46M | 2.33M | 1.93M | 325.33K | 73.68K | 146.70K | 46.68K | 55.20K | 3.45K |
Interest Income | 0.00 | 1.41M | 217.85K | 201.38K | 68.24K | 40.83K | 194.35K | 72.95K | 8.49K | 0.00 | 0.00 | 12.11K | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 1.41M | 1.28M | 4.10M | 3.69M | 924.69K | 274.77K | 171.20K | 73.22K | 0.00 | 0.00 | 323.00 | 2.45K | 408.00 | 115.00 |
Depreciation & Amortization | 167.90K | 1.52M | 483.57K | 2.42M | 2.05M | 330.44K | 284.95K | 250.45K | 25.52K | 355.82K | 0.00 | 12.11K | 0.00 | 0.00 | -494.00 |
EBITDA | 0.00 | -7.41M | -4.42M | -5.98M | -14.54M | -6.76M | -4.32M | -1.49M | -1.88M | -325.33K | -73.68K | -134.59K | -46.68K | -55.20K | -3.94K |
EBITDA Ratio | 0.00% | -118.66% | -4,603.40% | -82.14% | -61.57% | -116.21% | -506.04% | -245.75% | -836.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 0.00 | -8.94M | -4.91M | -12.56M | -16.58M | -7.09M | -4.95M | -1.55M | -1.83M | -681.16K | -73.68K | -146.70K | -46.68K | -55.20K | -3.45K |
Operating Income Ratio | 0.00% | -143.03% | -5,106.77% | -101.77% | -70.23% | -121.90% | -579.81% | -254.05% | -903.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | -10.33M | -6.55M | -4.84M | -9.28M | -2.80M | -2.13M | -135.52K | -182.22K | 0.00 | 0.00 | -200.33K | -64.61K | -408.00 | -609.00 |
Income Before Tax | 0.00 | -19.22M | -11.55M | -21.03M | -26.55M | -9.89M | -5.01M | -2.31M | -2.07M | -681.16K | -73.68K | -347.03K | -111.29K | -55.61K | -4.06K |
Income Before Tax Ratio | 0.00% | -307.63% | -12,026.00% | -170.42% | -112.47% | -170.08% | -585.80% | -379.65% | -1,022.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 1.23M | 67.82K | 1.06M | 1.14M | -183.08K | 934.99K | 685.84K | 266.41K | -355.82K | 0.00 | -11.78K | 0.00 | 0.00 | 0.00 |
Net Income | 0.00 | -18.97M | -1.85M | -22.09M | -27.70M | -9.71M | -5.01M | -2.31M | -2.06M | -681.16K | -73.68K | -347.03K | -111.29K | -55.61K | -4.06K |
Net Income Ratio | 0.00% | -303.60% | -1,925.34% | -179.03% | -117.31% | -166.93% | -585.80% | -379.53% | -1,018.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | -0.22 | -0.04 | -1.34 | -1.78 | -0.72 | -0.45 | -0.35 | -0.45 | -1.51 | -0.16 | -0.77 | -2.21 | -1.11 | -0.08 |
EPS Diluted | 0.00 | -0.22 | -0.04 | -1.34 | -1.78 | -0.72 | -0.45 | -0.35 | -0.45 | -1.51 | -0.16 | -0.77 | -2.21 | -1.11 | -0.08 |
Weighted Avg Shares Out | 0.00 | 87.84M | 45.20M | 16.48M | 15.52M | 13.41M | 11.20M | 6.66M | 4.59M | 451.21K | 451.21K | 451.21K | 50.38K | 50.00K | 50.00K |
Weighted Avg Shares Out (Dil) | 0.00 | 87.84M | 45.20M | 16.48M | 15.52M | 13.41M | 11.20M | 6.66M | 4.59M | 451.21K | 451.21K | 451.21K | 50.38K | 50.00K | 50.00K |
Vertical Peak Announces LOI to Sell California Operation and Board of Director Change
Nutritional High Provides an Update to the Management Cease Trade Order
Nutritional High Provides an Update to the Management Cease Trade Order
Nutritional High Provides an Update to the Management Cease Trade Order
Source: https://incomestatements.info
Category: Stock Reports